Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome

被引:39
|
作者
Robich, Michael P. [1 ,4 ]
Chu, Louis M. [4 ]
Chaudray, Mirnal [1 ]
Nezafat, Reza [2 ]
Han, Yuchi [2 ]
Clements, Richard T. [4 ]
Laham, Roger J. [2 ]
Manning, Warren J. [2 ,3 ]
Coady, Michael A. [5 ]
Sellke, Frank W. [4 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Div Cardiothorac Surg,Sch Med, Boston, MA 02215 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div,Sch Med, Boston, MA 02215 USA
[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiol, Boston, MA 02215 USA
[4] Brown Univ, Warren Alpert Sch Med, Dept Surg, Div Cardiothorac Surg, Providence, RI 02903 USA
[5] Rhode Isl Hosp, Div Cardiothorac Surg, Dept Surg, Providence, RI USA
关键词
ENDOTHELIAL GROWTH-FACTOR; CORONARY-ARTERY-DISEASE; TUMOR-GROWTH; ANGIOSTATIN; MYOCARDIUM; ENDOSTATIN; INHIBITORS; TARGETS; CELLS;
D O I
10.1016/j.surg.2010.04.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Resveratrol has been reported to induce angiogenesis in. ischemia; tissue. We hypothesized that high-dose resveratoral would improve native angiogenesis in a swine model of metabolic syndrome and chronic myocardial ischemia Methods. Yorkshire swine were fed a. normal diet (Control, n = 7), hypercholesterolemic diet (HCD, n = 7), or hypercholesterolemic diet with supplemental resveratrol (100 mg/kg/day orally, HCD-R, it = 7) beginning 1 month prior to surgery. Chronic ischemia was created by placing an. ameroid constrictor on the left curicumflex coronary artery After 7 weeks,,swine underwent functional AM, coronary angiography and serum and head tissue harvest for analysis Results. HCD-R animals had lower body mass in (P < 001), total cholesterol (P < .001), low-density lipoprotein (LDL, P < 001), blood glucose levels (P < .001), and systolic blood pressure (P = .03) than HCD) animals. There was no differente in regional myocardial fiinction at 7 weeks (P = .25). Coronary angiograms revealed no difference in nen pop collateral scores (P = 68) Staining fbr platelet endothelial cell adhesion molecule-I demonshated higher capillary density in the Control group (versus HCD and HCD-R; P = 02). Immunoblotting demonstrated decreased expression of the pro-angiogenic protein macula? endothelial (VE)-cadherin (P = 002) and an increase in anti-angiogenic poteins angiostatin (P = 001) and thrombospondin (P = 02) in the HCD and HCD-R groups Matrix metalloprotease 2 (MMP 2, P = 47) and MMP 9 (P = 12) were not different among pimps. Conclusion. Supplemental resveratrol positively modified cardiovascular risk factors including body mass index, cholesterol, glucose tolerance, and systolic blood pressure. However; it did not increase native collateral formation In the ischemia; myocardium This may be a result of increased angiostatin and thiombospondin leading to decreased expression of VE-cadherin and other pro-angiogenic factors (Surgery 2010,148 ; 453-62.)
引用
收藏
页码:453 / 462
页数:10
相关论文
共 50 条
  • [21] Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways
    Dull, Ana-Maria
    Moga, Marius Alexandru
    Dimienescu, Oana Gabriela
    Sechel, Gabriela
    Burtea, Victoria
    Anastasiu, Costin Vlad
    MOLECULES, 2019, 24 (04):
  • [22] Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors
    Jenny Ling-Yu Chen
    Chun-Kai Pan
    Yu-Sen Huang
    Ching-Yi Tsai
    Chun-Wei Wang
    Yu-Li Lin
    Sung-Hsin Kuo
    Ming-Jium Shieh
    Cancer Immunology, Immunotherapy, 2021, 70 : 391 - 404
  • [23] Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases
    Lancon, Allan
    Frazzi, Raffaele
    Latruffe, Norbert
    MOLECULES, 2016, 21 (03)
  • [24] Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma
    Kaicker, S
    McCrudden, KW
    Beck, L
    New, T
    Huang, JZ
    Frischer, JS
    Serur, A
    Kadenhe-Chiweshe, A
    Yokoi, A
    Kandel, JJ
    Yamashiro, DJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (06) : 1651 - 1655
  • [25] Phosphatase inhibitors with anti-angiogenic effect in vitro
    Sylvest, Lene
    Bendiksen, Christine Dam
    Houen, Gunnar
    APMIS, 2010, 118 (01) : 49 - 59
  • [26] Anti-angiogenic effect of aldosterone antagonist diuretics
    Guggino, S
    Weltin, D
    Chapelon, D
    Zaric, V
    Imbs, JL
    Stephan, D
    JOURNAL OF HYPERTENSION, 2002, 20 (08) : A5 - A5
  • [27] Anti-angiogenic effect of aldosterone antagonist diuretics
    Guggino, S
    Weltin, D
    Chapelon, D
    Imbs, JL
    Stephan, D
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2002, 95 (7-8): : 727 - 731
  • [28] Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Therapy
    Lam, Justina Yick Ching
    Ng, Matthew Chau Hsien
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2014, 23 (03) : 241 - 245
  • [29] Anti-angiogenic effect of tetraacetyl-phytosphingosine
    Bin Kwon, Yoo
    Kim, Chang Deok
    Kim, Bo Joong
    Kim, Min-Young
    Park, Chang Seo
    Yoon, Tae-Jin
    Seo, Young-Joon
    Suhr, Ki-Beom
    Park, Jang-Kyu
    Lee, Jeung-Hoon
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (04) : 311 - 317
  • [30] Anti-angiogenic effect of TGFβ in aqueous humor
    Hayasaka, K
    Oikawa, S
    Hashizume, E
    Kotake, H
    Midorikawa, H
    Sekikawa, A
    Hoshi, K
    Hara, S
    Ishigaki, Y
    Toyota, T
    LIFE SCIENCES, 1998, 63 (13) : 1089 - 1096